Patrick Frost, PhD

Patrick Frost, PhD

Feb 02, 2016

Group 6 Copy 46
-1
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Household Composting Toilets for Agriculture in Malawi

Ninety percent of Malawi does not have access to improved sanitation. 90% of the people also work in agriculture...

How do lichens withstand desiccation?

Lichens, symbioses between fungi and algae, survive levels of desiccation lethal to most organisms. We recently...

Creating a neural network that classifies Dinoflagellate species

I think we have the technology to develop an artificial intelligence model that can differentiate between Dinoflagellates...

Backer Badge Funded